Neumora Therapeutics, Inc. (NMRA)

NASDAQ: NMRA · IEX Real-Time Price · USD
12.08
+0.17 (1.43%)
Nov 28, 2023, 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 20222021
Selling, General & Admin
31.1224.55
Research & Development
91.7555.78
Other Operating Expenses
13157
Operating Expenses
135.87237.32
Operating Income
-135.87-237.32
Other Expense / Income
-4.97-0.01
Pretax Income
-130.9-237.31
Net Income
-130.9-237.31
Shares Outstanding (Basic)
213172
Shares Outstanding (Diluted)
213172
Shares Change
24.25%-
EPS (Basic)
-0.61-1.38
EPS (Diluted)
-0.61-1.38
Free Cash Flow
-115.41-76.24
Free Cash Flow Per Share
-0.54-0.44
EBITDA
-128.21-235.76
Depreciation & Amortization
2.71.55
EBIT
-130.9-237.31
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).